Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00498147
Status:
UNKNOWN
Last Update Posted:
2009-10-06
First Post:
2007-07-06
Brief Title:
Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
Sponsor:
Group Health Centre
Organization:
Group Health Centre
Study Overview
Official Title:
Does Managed Diabetes Care Decrease Cardiovascular Complications of Diabetes
Status:
UNKNOWN
Status Verified Date:
2009-10
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DECIDE
Brief Summary:
The primary objective of this study is to identify whether cardiovascular complication rates are lower in patients who participate in managed diabetes care in comparison to provincial and national rates This study will involve an electronic medical record EMR chart audit augmented by a manual review of hospital and other pertinent medical records as necessary
Detailed Description:
The DECIDE study will identify whether cardiovascular complication rates the composite rate of myocardial infarction MI Percutaneous Coronary Intervention PCI Coronary Artery Bypass Grafting CABG stroke carotid endarterectomy peripheral revascularization and peripheral amputation are lower in patients who participate in managed diabetes care by ADEC in comparison to provincial and national rates Comparison statistics will be provided by the Institute of Evaluative Sciences ICES Atlas 2003 and other Diabetes studies such as the 2005 DICE study Complications such as nephropathy and retinopathy will be documented along with hospitalization rates and all cause mortality Clinical outcomes relevant to diabetes management such as blood pressure and lipids will also be compared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None